SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline TSAT Q1 2026 Earnings Significant EPS Miss Amidst Strategic Transition Stock Rises EDN Q4 2024 Earnings Massive EPS Surprise Masks Broader Concerns as Stock Declines PRG Q1 2026 Earnings Massive EPS Beat Surprises But Market Response Remains Subdued Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress FCX Q1 2026 Earnings EPS Surges Past Estimates Amid Copper Price Strength